Jun 02, 2021 7:00am EDT Recro Expands Capabilities for Growing Clinical Trial Services (CTS) Offerings
May 14, 2021 9:15am EDT Recro Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares